0000899243-19-013992.txt : 20190517 0000899243-19-013992.hdr.sgml : 20190517 20190517161058 ACCESSION NUMBER: 0000899243-19-013992 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190517 DATE AS OF CHANGE: 20190517 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COOPER GLENN L MD CENTRAL INDEX KEY: 0001046351 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 19835756 MAIL ADDRESS: STREET 1: C/O 99 HAYDEN AVE STREET 2: 1 LEDGEMONT CENTER CITY: LEXINGTON STATE: MA ZIP: 02173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-15 0 0000730272 REPLIGEN CORP RGEN 0001046351 COOPER GLENN L MD C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 1 0 0 0 Common Stock 2019-05-15 4 A 0 923 0.00 A 40709 D Stock Option (Right to Buy) 67.71 2019-05-15 4 A 0 2109 0.00 A 2020-05-15 2029-05-15 Common Stock 2109 2109 D Mr. Cooper was awarded 923 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on May 15, 2020. The restricted stock units may be settled only be delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Award vests in full one year from grant date on May 15, 2020. /s/ Jeffrey P. Leduc (Attorney in Fact) 2019-05-17